Palvella Therapeutics PVLA Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Palvella Therapeutics's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Palvella Therapeutics's increase (decrease) in prepaid expense and other assets?
- Palvella Therapeutics (PVLA) reported increase (decrease) in prepaid expense and other assets of $357K in Q1 2026.
- How has Palvella Therapeutics's increase (decrease) in prepaid expense and other assets changed year-over-year?
- Palvella Therapeutics's increase (decrease) in prepaid expense and other assets increased by 143.6% year-over-year, from -$819K to $357K.
- What is the long-term trend for Palvella Therapeutics's increase (decrease) in prepaid expense and other assets?
- Over 4 years (2021 to 2025), Palvella Therapeutics's increase (decrease) in prepaid expense and other assets has grown at a -18.9% compound annual growth rate (CAGR), from $3.15M to -$1.36M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.